Thursday, December 31, 2015

INTRADAY STOCK CALLS 01.01.2016

BUY COALINDIA ABOVE 334.2 SL 330 TGT 337,340

BUY TATACHEM ABOVE 411.20 SL 407 TGT 415,418

INTRDAY CALLS 01.01.2016

BUY RELINFRA 560 TGT 570 SL 553

BY HINDPETRO 845 SL 836 TGT 851,855

HAPPY NEW YEAR 2016

HAPPY NEW YEAR 2016 

WISH U HAPPY NEW YEAR FRIENDS 2016


  NEW YEAR MARKS A NEW BEGINNING, NEW PEOPLE TO MEET,
 NEW ADVENTURES TO ENJOY AND NEW MEMORIES TO CREATE.
 WISHING YOU THE HAPPIEST NEW YEAR EVER!


NIFTY OVERVIEW UPTO 2030

Big Bull Rakesh Jhunjhunwala sees the Nifty touching 1,25,000 by 2030, considering the fact that company or corporate earnings are expected to grow by 16 per cent annually. The target is almost 13 times the index's close of 8,564.40 on Thursday.
Jhunjhunwala told a news channel that the Nifty has grown 10 times in the last 15 years and can jump 10-12 times in the next decade.
So, based on the assumption of strong economic growth, bounce back in corporate earnings to double digits and revival in investment cycle, the Nifty and the Sensex can reach these levels which look more like a tall task.
When asked about the targets are they working with for the next 15 years, most of analysts agreed that the bull run is here to say, but said there are caveats and assumptions which needs to get fulfilled first before we can achieve these targets.
If we look deeper into the data, the Nifty has moved from the levels of 943 recorded on 29th April 2003, to 8600 levels as of today (4th December 2014), at an yearly compounded growth rate of above 20 per cent.
"So, if we apply the same growth rate, 125000 is possible by 2030 on the Nifty & 4,00,000 on the Sensex with support from strong economy growth, stable government at the Center, as well as infrastructure & technology development," says Kiran Kumar Kavikondala, Director & CEO, WealthRays Securities.
"Equities are expected to perform well over the next decade in India along with corporate earnings expected to grow above 15 per cent and EPS of Indian bourses set to move higher, pushing the valuations to these levels," he adds.
By 2018, Kavikondala estimates the Nifty to cross 15000; by 2020, 35000; by 2025, 60,000 and by 2030, he expects the Nifty to cross 1 lakh, keeping in view the strong economy growth.
Most global brokerage firms have expressed their confidence in the India's story with Narender Modi at the helm of things. This is reflected in their overweight stance on the India markets, which have outperformed global markets in the year. The Indian markets are still trading below previous valuation peaks of 25x, which also supports the optimism.
The Indian stock market created history last week on Friday, when the total investor wealth hit a record high of Rs 100 trillion in trade on the BSE, which also puts it in the ten largest exchanges of the world in terms of total market capitalisation of listed firms.

INDIAS MOBILE SUBSCRIPTION

 India's mobile phone subscriber base peaked to more than 1 billion users for the first time, data released by the telecom regulator on Wednesday showed, making India the only country after China to achieve that milestone.

Total wireless subscribers in Asia's third-largest economy rose to more than 1 billion at the end of October from 996.7 million at September-end, the data showed.

Mobile subscriptions in India have surged in recent years, helped by the launch of cheaper smartphones and record low call rates as a result of a cut throat competition among mobile phone operators to expand customer base.

STOCK IN NEWS

USD INR TRADING RANGE

USDINR trading range for the day is 66.46-66.8. 

Rupee snapped an eight-day gaining streak on dollar demand from oil importers to meet month-end purchases amid buying by foreign banks. 
India's current account deficit (CAD) narrowed to $8.2 billion (1.6 percent of GDP) in the September 2015 quarter. RBI says Gov't surplus cash balance with RBI for auction was 1.39tn rupees as of December 28 


EURINR trading range for the day is 72.96-73.38. 

Euro gained after the Christmas break, with nothing significant on the data front over the week apart from US jobless claims scheduled for Thursday. From euro zone perspective, the week offers up very little, with only adjusted Spanish retail sales and the Italian Manufacturing Confidence Index scheduled for Tuesday. The number of job-seekers in France declined in November, official data showed. 

WISH U HAPPY NEW YEAR ALL VIEWERS 2016

WISH U HAPPY NEW YEAR ALL VIEWERS 2016

Wednesday, December 30, 2015

STOCK NEWS


Cadila hits 52-week low, down 15% on USFDA warning for 2 units


"Company has received a warning letter issued by the US Food and Drug Administration relating to its Moraiya formulation facility and Ahmedabad oncology API facility (Zyfine)," 


says the Gujarat-based pharma company in its filing to exchanges.


The company further says it is working hard to ensure that commitments made to USFDA are fully completed, adding it will continue to take all necessary steps to ensure that US FDA is fully satisfied with remediation of these two facilities. Cadila had received Form 483 observations for Moraiya facility in August 2014 and for Zyfine facility in December 2014. Lack of standard operating procedures, quality controls etc were some of observations highlighted in Moraiya facility. Moraiya facility contributes around 25 percent to its US sales that increased 16 percent year-on-year in September quarter. Analysts see possible delays in USFDA approvals expected in October-March FY16. They say the company has initiated site transfer for critical products such as Nexium, Toprol generic from Moraiya facility.

 According to them, new formulations facility in SEZ received establishment inspection report from the USFDA may provide visibility for US sales. They say content of warning letter will be key, adding there will be no financial impact from warning letter for Ahemdabad API facility. Zydus Cadila group has eight manufacturing facilities, which spread over five states of India. It has formulations manufacturing plants at Moraiya (Ahmedabad), Baddi, Sikkim and Goa in India while finished dosage plant in Brazil. Its API manufacturing facilities are at Dabhasa, Ankleshwar and Navi Mumbai (Zydus Takeda). The group aims to record revenue of Rs 10,000 crore by 2015-16 (against Rs 8,600 crore in FY15). At 11:39 hours IST, the scrip of Cadila Healthcare was quoting at Rs 326.55, down Rs 58.60, or 15.21 percent amid high volumes on the BSE. 


DISCLAIMER

Disclosure : The calls made herein are for informational purposes and are not recommendations to any person to buy or sell any securities. The information is derived from sources that are deemed to be reliable but its accuracy and completeness are not guaranteed. The above calls are based on the theory of technical analysis. The author does not accept any liability for the use of this column. Readers of this column who buy or sell securities based on the information in this column are solely responsible for their actions. The author may r trade or have positions in any of the stocks mentioned in this column.
Nothing published on this site / article should be considered as an investment advice. It's not an offer to buy or sell Nor any SMS carry any BUY OR SELL Signal....... 
The author and / or his associates maybe trading, or may have positions, in one or more of the stocks mentioned in the information / article / site. Our clients may have position in the above written stock / stocks.

INTRADAY CALLS

SELL NIFTY FUTURE 7900 SL 7930 TGT 7880,7870


SELL BANK NIFTY FUTURE 16930 SL 16975 TGT 16850,16800 

MARKET CUES

Market Cues Indian markets are expected to open flat tracking the SGX Nifty and Asian peers. U.S. markets closed in the red as downbeat housing data raised concerns about the economy. The National Association of Realtors' pending home sales index fell by 0.9% in November, as against expectations of an increase. European markets too declined led by further drop in commodity prices leading to a drop in energy and metal/mining stocks. Trading activity remained light across both, US and Europe ahead of Friday's New Year's Day holiday. Indian markets closed lower led by some selling pressure ahead of the F&O expiry, in the absence of any other major trigger. Volumes continued to remain low led on    account of the holiday season.

BANK NIFTY CALLS

SELL BANK NIFTY  16915 SL 16975 TGT 16850,16800

INTRADAY CALLS

SELL HINDPETRO   836 SL 844 TGT 829,823 

BUY TECH MAHINDRA 523 SL 517 TGT 530,534
Market Cues

 Indian markets are expected to open flat tracking the SGX Nifty and Asian peers. U.S. markets closed sharply higher led by better than expected consumer confidence data for December.

 Volumes were however low ahead of the New year’s day holiday with many traders remaining on the sidelines.
European markets bounced back after a pull back in the previous session to close firmly in the green. Trading activity remained light in Europe as well ahead of Friday's New Year's Day holiday.
Indian markets had a choppy session with markets managing to close barely in the positive.
The late recovery was on account of positive European cues.
Volumes continued to remain low led on account of the holiday season